Cellular Biomedicine Group Announces Upcoming Presentation to Release 48-Week Data from Phase I Clinical Trial for AlloJoin™ Off-the-Shelf Allogeneic Stem Cell Therapy for Knee Osteoarthritis

World News: . []

SHANGHAI China and CUPERTINO Calif March 14 2018 GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc NASDAQCBMG CBMG or the Company a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for ca ncer an...

More news and information about Cellular Biomedicine Group Inc.

Published By:

Globe Newswire: 11:30 GMT Wednesday 14th March 2018

Published: .

Search for other references to "cellular" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us